Table 2.
Patients’ characteristics and results (prospective study).
| Group | Urolithiasis after URS | p-Value 5 | |
|---|---|---|---|
| Stone free (n = 14) |
Residual stone (n = 7) |
||
| Sex (male/female) | 5/9 | 6/1 | 0.0635 |
| median (IQR 1) | median (IQR 1) | ||
| Age (years) | 61 (54–70) | 74 (57–77) | 0.3690 |
| uFL-OPN 2 (ng/mL/mg protein) |
120,003 (15.5–49,527) |
35.6 (8.8–18,322) |
0.0385 |
| Gal3C-S-OPN 3 /uFL-OPN 2 (MFI 4/uFL-OPN 2) |
0.02 (0.001–10.2) |
1.87 (0.026–88.6) |
0.0030 |
| Follow-up period (day) | 345 (213–407) | 206 (150–525) | 0.5815 |
1 IQR, Interquartile range; 2 uFL-OPN, Urinary full-length-osteopontin; 3 Gal3C-S-OPN, Gal3C-S lectin reactive osteopontin; 4 MFI, mean fluorescence intensity; 5 p-value, Mann–Whitney U-test.